Beijing | January 3, 2026
China has introduced a new tax on contraceptives as part of its broader push to reverse the country’s declining birth rate and address long-term demographic challenges.
Under the policy, a 13% value-added tax (VAT) now applies to condoms and contraceptive drugs, effectively raising their retail prices nationwide. The move aligns with the government’s strategy to encourage higher fertility amid concerns over a rapidly aging population and shrinking workforce.
Chinese tax and health authorities have linked the measure to national population goals, as birth rates continue to fall despite the end of the one-child policy and the introduction of incentives encouraging families to have more children.
Officials have not named specific enforcement timelines or exemptions, but the tax is expected to impact family planning decisions across urban and rural areas. Public health experts and advocacy groups have expressed concern that higher contraceptive costs could limit access, particularly for low-income communities, and potentially affect sexual health outcomes.
China has been rolling out a range of demographic measures in recent years, including childcare subsidies, housing incentives, and workplace reforms. The contraceptive tax marks one of the more controversial steps, highlighting the growing urgency within the government to confront the country’s population slowdown.
The long-term impact of the policy on birth rates and public health remains under close observation.
